drugset / Trial / NCT03299322

A Study to Assess Jia Wei Yang He Formula as a Plus Therapy in the Treatment of Persistent Asthma

NCT03299322 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Investigators aimed to assess Jia Wei Yang He Formula as a plus therapy in the treatment of persistent asthma and to explore Airway Microbiome variation of Asthma by Traditional Chinese Medicine treatment

Timeline

Start
2017-10-01
Primary completion
2025-12-01
Completion
2025-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Jia Wei Yang He granule Unknown 9.25 g Oral
Subject Jia Wei Yang He granule Unknown 18.5 g Oral

Indications